Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -47.529% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) Cc1cccc(-n2nnc(C(=O)N3CCc4ccccc4C3)c2N)c1
b.) CC(C)(O)C1=NOC(c2ccccc2)C1
c.) CC1=C(C(=O)N2CCOCC2)C(c2ccccc2F)C2=C(CCCC2=O)N1
d.) Cc1sc2ncnc(N3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)c2c1C
e.) Oc1ccc(/C=N/Nc2ccnc3cc(Cl)ccc23)cc1O
Answer: d. Cc1sc2ncnc(N3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2ncnc(N3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)c2c1C
Cc1sc2ncnc(N3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)c2c1C
4-[4-(4-bromophenyl)sulfonylpiperazin-1-yl]-5,6-dimethylthieno[2,3-d]pyrimidine